I would guess we will all be hearing quite a lot about this fat pill soon, especially if it will be sold over the counter. I mean, come on, how many millions of American have bought into the “thin is in” paradigm but don't want to exercise or (perish the thought) change their diets?
GlaxoSmithKline PLC's Alli won approval from federal regulators to become the first weight-loss drug available without a prescription in the U.S., though the product's sometimes-unpleasant side effects may limit widespread use.
The Food and Drug Administration said it will allow over-the-counter use of the drug only for overweight adults when combined with a program that includes a reduced-calorie, low-fat diet and an exercise program. Alli, known generically as orlistat, is sold at a higher dose as the prescription drug Xenical by Roche Holding AG.
GlaxoSmithKline said it will price Alli at about $2 for three capsules, which is a typical day's dose of the drug, and will sell it widely in drugstores, grocery stores and other outlets where nonprescription drugs are sold.
but perhaps the news/PR will focus on:
The new drug will also have to overcome consumers' concerns about unpleasant digestive side effects that can include incontinence and oily stools.
which doesn't really interest me much.